Anebulo Pharmaceuticals Inc expected to post a loss of 12 cents a share - Earnings Preview

Anebulo Pharmaceuticals

05/09/2023 14:04

* Anebulo Pharmaceuticals Inc  ANEB.OQ   ANEB.O  is expected
to show no change in quarterly revenue when it reports 
results on September 7 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Anebulo
Pharmaceuticals
Inc is for a loss of 12 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Anebulo
Pharmaceuticals Inc is $8​, above​ its last closing price
of $2.66. ​​​

This summary was machine generated September 5 at 13:04 GMT. 
All figures in US dollars  unless otherwise stated